Alterity Therapeutics (ATHE) Total Current Liabilities (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Total Current Liabilities of $1.7 million for Q4 2025, down 4.49% year-over-year from $1.8 million in Q4 2024, and down 25.01% quarter-over-quarter from $2.3 million in Q2 2025.
Alterity Therapeutics (ATHE) Total Current Liabilities (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 4.49% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 4.49% YoY), while the FY2025 annual figure was $2.3 million, down 36.08% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $1.7 million, down from $2.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $4.2 million in Q2 2022, with the low at -$5.1 million in Q2 2024.
- The 5-year median for Total Current Liabilities is $2.3 million (2025), against an average of $1.6 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities plunged 11742.89% in 2024, then jumped 144.37% in 2025.
- Alterity Therapeutics' Total Current Liabilities stood at $2.7 million in 2021, then climbed by 25.41% to $3.4 million in 2022, then decreased by 14.91% to $2.9 million in 2023, then sank by 39.23% to $1.8 million in 2024, then declined by 4.49% to $1.7 million in 2025.
- Business Quant data shows ATHE's Total Current Liabilities at $1.7 million in Q4 2025, $2.3 million in Q2 2025, and $1.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 630.93 Mn |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.70 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Jun 30, 2024 | -5.10 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Jun 30, 2023 | 43,820.17 |
| Dec 31, 2022 | 3.44 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Jun 30, 2021 | 2.36 Mn |
| Dec 31, 2020 | 2.22 Mn |
| Jun 30, 2020 | 1.78 Mn |
| Dec 31, 2019 | 2.21 Mn |
| Jun 30, 2019 | 2.33 Mn |
| Dec 31, 2018 | 2,310.88 |
| Jun 30, 2018 | 2.00 Mn |
| Dec 31, 2017 | 1.40 Mn |
| Jun 30, 2017 | 1,194.80 |
| Dec 31, 2016 | 2.14 Mn |
| Jun 30, 2016 | 1,760.20 |